Literature DB >> 30158201

Extrahepatic PPARα modulates fatty acid oxidation and attenuates fasting-induced hepatosteatosis in mice.

Chad N Brocker1, Daxesh P Patel1, Thomas J Velenosi1, Donghwan Kim1, Tingting Yan1, Jiang Yue1, Guolin Li1, Kristopher W Krausz2, Frank J Gonzalez2.   

Abstract

PPARα (PPARA), expressed in most oxidative tissues, is a major regulator of lipid homeostasis; hepatic PPARA plays a critical role during the adaptive fasting response by promoting FA oxidation (FAO). To clarify whether extrahepatic PPARA activity can protect against lipid overload when hepatic PPARA is impaired, lipid accumulation was compared in WT (Ppara +/+), total body Ppara-null (Ppara -/-), and hepatocyte-specific Ppara-null (Ppara ΔHep) mice that were fasted for 24 h. Histologic staining indicated reduced lipid accumulation in Ppara ΔHep versus Ppara -/- mice, and biochemical analyses revealed diminished medium- and long-chain FA accumulation in Ppara ΔHep mouse livers. Hepatic PPARA target genes were suppressed in both mouse models. Serum FFAs increased in all genotypes after fasting but were highest in Ppara -/- mice. In Ppara ΔHep mice, FAO genes were increased in brown adipose tissue, heart, and muscle, and total lipase activity was elevated in the muscle and heart, suggesting increased lipid utilization. Thus, extrahepatic PPARA activity reduces systemic lipid load when hepatic lipid metabolism is impaired by elevating FAO and lipase activity in other tissues and, as a result, protects against fasting-induced hepatosteatosis. This has important clinical implications in disease states with impaired hepatic PPARA function, such as nonalcoholic steatohepatitis and nonalcoholic fatty liver disease.
Copyright © 2018 Fuchs et al.

Entities:  

Keywords:  caloric restriction; lipase; nuclear receptors; peroxisome proliferator-activated receptor

Mesh:

Substances:

Year:  2018        PMID: 30158201      PMCID: PMC6210912          DOI: 10.1194/jlr.M088419

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  40 in total

1.  Regulation of lipoprotein lipase in adipose and muscle tissues during fasting.

Authors:  M J Ladu; H Kapsas; W K Palmer
Journal:  Am J Physiol       Date:  1991-05

Review 2.  The role and regulation of the peroxisome proliferator activated receptor alpha in human liver.

Authors:  Sander Kersten; Rinke Stienstra
Journal:  Biochimie       Date:  2017-01-08       Impact factor: 4.079

3.  Bimodal action of miroestrol and deoxymiroestrol, phytoestrogens from Pueraria candollei var. mirifica, on hepatic CYP2B9 and CYP1A2 expressions and antilipid peroxidation in mice.

Authors:  Latiporn Udomsuk; Thaweesak Juengwatanatrakul; Waraporn Putalun; Kanokwan Jarukamjorn
Journal:  Nutr Res       Date:  2011-12-29       Impact factor: 3.315

4.  In vivo deletion of CAR resulted in high bone mass phenotypes in male mice.

Authors:  Hwa Young Cho; Ju-Yeon Jung; Hyojung Park; Jae-Yeon Yang; Solip Jung; Jee Hyun An; Sun Wook Cho; Sang Wan Kim; Seong Yeon Kim; Jung Eun Kim; Young Joo Park; Chan Soo Shin
Journal:  J Cell Physiol       Date:  2014-05       Impact factor: 6.384

5.  Nuclear receptor expression links the circadian clock to metabolism.

Authors:  Xiaoyong Yang; Michael Downes; Ruth T Yu; Angie L Bookout; Weimin He; Marty Straume; David J Mangelsdorf; Ronald M Evans
Journal:  Cell       Date:  2006-08-25       Impact factor: 41.582

6.  A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders.

Authors:  T C Leone; C J Weinheimer; D P Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

7.  Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis.

Authors:  I Tavares de Almeida; H Cortez-Pinto; G Fidalgo; D Rodrigues; M E Camilo
Journal:  Clin Nutr       Date:  2002-06       Impact factor: 7.324

8.  Lipocalin-2 (LCN2) regulates PLIN5 expression and intracellular lipid droplet formation in the liver.

Authors:  Anastasia Asimakopoulou; Erawan Borkham-Kamphorst; Marc Henning; Eray Yagmur; Nikolaus Gassler; Christian Liedtke; Thorsten Berger; Tak W Mak; Ralf Weiskirchen
Journal:  Biochim Biophys Acta       Date:  2014-07-31

9.  The Detrimental Role Played by Lipocalin-2 in Alcoholic Fatty Liver in Mice.

Authors:  Yan Cai; Alvin Jogasuria; Huquan Yin; Ming-Jiang Xu; Xudong Hu; Jiayou Wang; Chunki Kim; Jiashin Wu; Kwangwon Lee; Bin Gao; Min You
Journal:  Am J Pathol       Date:  2016-07-15       Impact factor: 4.307

10.  Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators.

Authors:  S S Lee; T Pineau; J Drago; E J Lee; J W Owens; D L Kroetz; P M Fernandez-Salguero; H Westphal; F J Gonzalez
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

View more
  20 in total

1.  Loss of hepatic PPARα promotes inflammation and serum hyperlipidemia in diet-induced obesity.

Authors:  David E Stec; Darren M Gordon; Jennifer A Hipp; Stephen Hong; Zachary L Mitchell; Natalia R Franco; J Walker Robison; Christopher D Anderson; Donald F Stec; Terry D Hinds
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-09-04       Impact factor: 3.619

2.  Hepatocyte peroxisome proliferator-activated receptor α regulates bile acid synthesis and transport.

Authors:  Cen Xie; Shogo Takahashi; Chad N Brocker; Shijun He; Li Chen; Guomin Xie; Katrina Jang; Xiaoxia Gao; Kristopher W Krausz; Aijuan Qu; Moshe Levi; Frank J Gonzalez
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2019-06-10       Impact factor: 4.698

3.  Long non-coding RNA G23Rik attenuates fasting-induced lipid accumulation in mouse liver.

Authors:  Donghwan Kim; Bora Kim; Chad N Brocker; Kritika Karri; David J Waxman; Frank J Gonzalez
Journal:  Mol Cell Endocrinol       Date:  2022-07-30       Impact factor: 4.369

Review 4.  Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH).

Authors:  Xiaohan Xu; Kyle L Poulsen; Lijuan Wu; Shan Liu; Tatsunori Miyata; Qiaoling Song; Qingda Wei; Chenyang Zhao; Chunhua Lin; Jinbo Yang
Journal:  Signal Transduct Target Ther       Date:  2022-08-13

Review 5.  Bile acid and receptors: biology and drug discovery for nonalcoholic fatty liver disease.

Authors:  Ting-Ying Jiao; Yuan-di Ma; Xiao-Zhen Guo; Yun-Fei Ye; Cen Xie
Journal:  Acta Pharmacol Sin       Date:  2022-02-25       Impact factor: 7.169

6.  Influenza virus infection affects insulin signaling, fatty acid-metabolizing enzyme expressions, and the tricarboxylic acid cycle in mice.

Authors:  Marumi Ohno; Toshiki Sekiya; Naoki Nomura; Taku Ji Daito; Masashi Shingai; Hiroshi Kida
Journal:  Sci Rep       Date:  2020-07-02       Impact factor: 4.379

7.  Bromide alleviates fatty acid-induced lipid accumulation in mouse primary hepatocytes through the activation of PPARα signals.

Authors:  Yujie Shi; Wenxiang Zhang; Yinlong Cheng; Chang Liu; Siyu Chen
Journal:  J Cell Mol Med       Date:  2019-04-29       Impact factor: 5.310

Review 8.  PPAR control of metabolism and cardiovascular functions.

Authors:  David Montaigne; Laura Butruille; Bart Staels
Journal:  Nat Rev Cardiol       Date:  2021-06-14       Impact factor: 32.419

9.  Human amniotic mesenchymal stem cells-conditioned medium protects mice from high-fat diet-induced obesity.

Authors:  Hui-Lan Tan; Xiao-Hui Guan; Min Hu; Jie Wu; Rong-Zhen Li; Ling-Fang Wang; Hou-Da Huang; Zhen-Ping Yu; Xiao-Yu Wang; Yun-Fei Xiao; Ke-Yu Deng; Hong-Bo Xin
Journal:  Stem Cell Res Ther       Date:  2021-06-26       Impact factor: 6.832

10.  Rapamycin-Loaded mPEG-PLGA Nanoparticles Ameliorate Hepatic Steatosis and Liver Injury in Non-alcoholic Fatty Liver Disease.

Authors:  Ruifang Zhao; Meilin Zhu; Shuang Zhou; Weiyue Feng; Hanqing Chen
Journal:  Front Chem       Date:  2020-05-28       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.